UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The interplay between the microbiota, diet and T regulatory cells in the preservation of the gut barrier in inflammatory bowel disease

Frontiers in microbiology, 2023-12, Vol.14, p.1291724-1291724

2023

Volltextzugriff (PDF)

The unusual suspects--innate lymphoid cells as novel therapeutic targets in IBD

Nature reviews. Gastroenterology & hepatology, 2015-05, Vol.12 (5), p.271-283

2015

Volltextzugriff (PDF)

Genetic variants alter T-bet binding and gene expression in mucosal inflammatory disease

PLoS genetics, 2017-02, Vol.13 (2), p.e1006587-e1006587

2017

Volltextzugriff (PDF)

Reply

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.1031-1032

2023

Volltextzugriff (PDF)

Well controlled maternal inflammatory bowel disease does not increase the risk of abnormal neurocognitive outcome screening in offspring

Brain, behavior, & immunity. Health, 2024-10, Vol.40, p.100827, Article 100827

2024

Volltextzugriff (PDF)

Preconception, antenatal and postpartum management of inflammatory bowel disease

Australian journal of general practice, 2022-10, Vol.51 (10), p.747-753

2022

Volltextzugriff (PDF)

A case of visceral leishmaniasis masquerading as autoimmune hepatitis

Medical journal of Australia, 2024-08, Vol.221 (6), p.299-301

2024

Volltextzugriff (PDF)

Resolving intestinal fibrosis through regenerative medicine

Current opinion in pharmacology, 2019-12, Vol.49, p.90-94

2019

Volltextzugriff (PDF)

P46 A common IL2RA polymorphism alters natural killer cell immunophenotype and function in crohn’s disease, with implications for IL-2 based therapy

Gut, 2023-06, Vol.72 (Suppl 2), p.A69-A70

2023

Volltextzugriff (PDF)

Reply

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.1031-1032

2023

Volltextzugriff (PDF)

Reply

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.1031

2023

Volltextzugriff (PDF)

773 A COMMON IL2RA POLYMORPHISM ALTERS NATURAL KILLER CELL IMMUNOPHENOTYPE AND FUNCTION IN CROHN'S DISEASE, WITH IMPLICATIONS FOR IL-2 BASED THERAPY

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-164-S-165

2023

Volltextzugriff (PDF)

EP1306: PREGNANCY IN CROHN'S AND COLITIS - OBSERVATONS, LEVELS AND OUTCOMES EXTENSION (PICCOLO-X) STUDY: BIOLOGIC THERAPY REDUCES FAECAL CALPROTECTIN AND THE NEED FOR CORTICOSTEROIDS IN PREGNANT WOMEN WITH INFLAMMATORY BOWEL DISEASE

Gastroenterology (New York, N.Y. 1943), 2022-05, Vol.162 (7), p.S-1095

2022

Volltextzugriff (PDF)

676 PHAMRACOKINETICS OF VEDOLIZUMAB AND USTEKINUMAB IN PREGNANT WOMEN WITH INFLAMMATORY BOWEL DISEASE AND THEIR INFANTS EXPOSED IN-UTERO

Gastroenterology (New York, N.Y. 1943), 2023-05, Vol.164 (6), p.S-132-S-132

2023

Volltextzugriff (PDF)

Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease

Gut, 2016-04, Vol.65 (4), p.584-594

2016

Volltextzugriff (PDF)

Correction of Defective T-Regulatory Cells From Patients With Crohn’s Disease by Ex Vivo Ligation of Retinoic Acid Receptor-α

Gastroenterology (New York, N.Y. 1943), 2019-05, Vol.156 (6), p.1775-1787

2019

Volltextzugriff (PDF)

Thrombocytosis and Transaminitis in Infants Born to Women With Inflammatory Bowel Disease Is Associated With Exposure to Maternal Inflammation In Utero

Inflammatory bowel diseases, 2024-02

2024

Volltextzugriff (PDF)

Ustekinumab levels in pregnant women with inflammatory bowel disease and infants exposed in utero

Alimentary pharmacology & therapeutics, 2022-03, Vol.55 (6), p.700-704

2022

Volltextzugriff (PDF)

Toxicity and response to thiopurines in patients with inflammatory bowel disease

Expert review of gastroenterology & hepatology, 2015-07, Vol.9 (7), p.891-900

2015

Volltextzugriff (PDF)

Colonic cytomegalovirus DNA detection by polymerase chain reaction does not influence outcomes in inflammatory bowel disease and immunosuppressed cohorts

Internal medicine journal, 2024-02, Vol.54 (2), p.283-289

2024

Volltextzugriff (PDF)

Impact of a pharmacist‐led thiopurine monitoring service in outpatients with inflammatory bowel disease

Internal medicine journal, 2023-05, Vol.53 (5), p.779-786

2023

Volltextzugriff (PDF)

How accurate are hospital scales?

Medical journal of Australia, 2011-06, Vol.194 (12), p.665-665

2011

Volltextzugriff (PDF)

Safety of in utero exposure to maternal IBD pharmacotherapies

Nature reviews. Gastroenterology & hepatology, 2022-04, Vol.19 (4), p.213-214

2022

Volltextzugriff (PDF)

Interleukin 6 Increases Production of Cytokines by Colonic Innate Lymphoid Cells in Mice and Patients With Chronic Intestinal Inflammation

Gastroenterology (New York, N.Y. 1943), 2015-08, Vol.149 (2), p.456-467.e15

2015

Volltextzugriff (PDF)

Vedolizumab and Ustekinumab Levels in Pregnant Women With Inflammatory Bowel Disease and Infants Exposed In Utero

Clinical gastroenterology and hepatology, 2024-03

2024

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(28)

Publikationsform

Sprache

Englisch
(35)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(23)
Science & Technology
(23)
Humans
(17)
Gastroenterology & Hepatology
(15)
Inflammatory Bowel Disease
(14)
Inflammatory Bowel Diseases
(8)
Female
(7)
Pregnancy
(6)
Inflammatory Bowel Diseases - Drug Therapy
(5)
Animals
(4)
Crohns Disease
(4)
General & Internal Medicine
(4)
Ibd
(4)
Inflammation
(4)
Medicine, General & Internal
(4)
Azathioprine - Therapeutic Use
(3)
Crohn Disease - Immunology
(3)
Crohn's Disease
(3)
Cytokines
(3)
Intestine
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The interplay between the microbiota, diet and T regulatory cells in the preservation of the gut barrier in inflammatory bowel disease

The unusual suspects--innate lymphoid cells as novel therapeutic targets in IBD

Genetic variants alter T-bet binding and gene expression in mucosal inflammatory disease

Reply

Well controlled maternal inflammatory bowel disease does not increase the risk of abnormal neurocognitive outcome screening in offspring

Preconception, antenatal and postpartum management of inflammatory bowel disease

A case of visceral leishmaniasis masquerading as autoimmune hepatitis

Resolving intestinal fibrosis through regenerative medicine

P46 A common IL2RA polymorphism alters natural killer cell immunophenotype and function in crohn’s disease, with implications for IL-2 based therapy

Reply

Reply

773 A COMMON IL2RA POLYMORPHISM ALTERS NATURAL KILLER CELL IMMUNOPHENOTYPE AND FUNCTION IN CROHN'S DISEASE, WITH IMPLICATIONS FOR IL-2 BASED THERAPY

EP1306: PREGNANCY IN CROHN'S AND COLITIS - OBSERVATONS, LEVELS AND OUTCOMES EXTENSION (PICCOLO-X) STUDY: BIOLOGIC THERAPY REDUCES FAECAL CALPROTECTIN AND THE NEED FOR CORTICOSTEROIDS IN PREGNANT WOMEN WITH INFLAMMATORY BOWEL DISEASE

676 PHAMRACOKINETICS OF VEDOLIZUMAB AND USTEKINUMAB IN PREGNANT WOMEN WITH INFLAMMATORY BOWEL DISEASE AND THEIR INFANTS EXPOSED IN-UTERO

Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease

Correction of Defective T-Regulatory Cells From Patients With Crohn’s Disease by Ex Vivo Ligation of Retinoic Acid Receptor-α

Thrombocytosis and Transaminitis in Infants Born to Women With Inflammatory Bowel Disease Is Associated With Exposure to Maternal Inflammation In Utero

Ustekinumab levels in pregnant women with inflammatory bowel disease and infants exposed in utero

Toxicity and response to thiopurines in patients with inflammatory bowel disease

Colonic cytomegalovirus DNA detection by polymerase chain reaction does not influence outcomes in inflammatory bowel disease and immunosuppressed cohorts

Impact of a pharmacist‐led thiopurine monitoring service in outpatients with inflammatory bowel disease

How accurate are hospital scales?

Safety of in utero exposure to maternal IBD pharmacotherapies

Interleukin 6 Increases Production of Cytokines by Colonic Innate Lymphoid Cells in Mice and Patients With Chronic Intestinal Inflammation

Vedolizumab and Ustekinumab Levels in Pregnant Women With Inflammatory Bowel Disease and Infants Exposed In Utero

Suchergebnisse filtern